Loading...
Indian Pharmaceutical Exporter · #5 for Axitinib · $5.7K export value · DGFT Verified
Aprazer Healthcare Private Limited is the #5 Indian exporter of Axitinib with $5.7K in export value and 12 verified shipments. Aprazer Healthcare Private Limited holds a 6.1% market share in Axitinib exports across 4 countries.
| UNITED ARAB EMIRATES | $8.5K | 13 | 9.5% |
| VENEZUELA | $5.2K | 13 | 5.9% |
| MAURITIUS | $4.9K | 17 | 5.4% |
| UGANDA | $2.2K | 3 | 2.5% |
| LEBANON | $2.1K | 7 | 2.3% |
| NIGERIA | $1.9K | 9 | 2.1% |
India exports Axitinib to 28 countries. The top destination is IRAQ (32.9%), followed by MEXICO and BRAZIL.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ATLAS TRADING COMPANY | IRAQ | $8.5K | 11 |
| MIDAN PHARMA SCIENTIFIC BUREAU | IRAQ | $6.6K | 3 |
| SKIN LINE LOGISTIC | IRAQ | $3.5K | 12 |
| ZMC EXPRESS CARGO FZCO | UNITED ARAB EMIRATES | $3.2K | 9 |
| MIDAN PHARMA | IRAQ | $3.1K | 7 |
| GLOBAL CARE PHARMA, C.A. | VENEZUELA | $2.9K | 6 |
| ARROW GENERAL TRADING FZE | UNITED ARAB EMIRATES | $2.5K | 2 |
| SARTAJ ENTERPRIESES LIMITED | AFGHANISTAN | $1.2K | 2 |
| K.S. ATLAS DIS TIC.LTD STI | TURKEY | $1.2K | 3 |
| GLOBAL AVIATION SERVICES CARGO | SPAIN | $1.0K | 2 |
India's Axitinib is purchased by 77 buyers worldwide. The top buyer is ATLAS TRADING COMPANY (IRAQ), followed by MIDAN PHARMA SCIENTIFIC BUREAU and SKIN LINE LOGISTIC.
India exported $60.8K worth of Axitinib through 209 shipments from 56 suppliers to 28 countries, serving 77 buyers globally. Aprazer Healthcare Private Limited contributes $5.7K to this total, accounting for 6.1% of India's Axitinib exports.
Aprazer Healthcare Private Limited's average Axitinib shipment value is $474 per consignment, based on 12 shipments totaling $5.7K.
Aprazer Healthcare Private Limited ranks #5 among 56 Indian Axitinib exporters with a 6.1% market share. The top 3 exporters are SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED ($10.8K), GALAXY SUPER SPECIALITY ($9.4K), RMPL PHARMA LLP ($7.2K). Aprazer Healthcare Private Limited processed 12 shipments to 4 destination countries.
What Aprazer Healthcare Private Limited must comply with to export Axitinib to its top destination countries
Approval Process
Generic registration under Mexican health law. NOM standards apply.
Timeline: 12–18 months
GMP & Export Requirements
Mexican GMP (NOM-059-SSA1); COFEPRIS overseas inspection or PIC/S certificate
Sanitary Import Permit from COFEPRIS; import licence via SAT
Note: COFEPRIS participates in PIC/S, easing recognition of PIC/S certificates from Indian authorities.
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | RMPL PHARMA LLP | $7.2K | 9 | 4 | $798 |
| 4 | MEDINEX HEALTHCARE | $6.4K | 9 | 1 | $710 |
| 5 | APRAZER HEALTHCARE PRIVATE LIMITED ★ | $5.7K | 12 | 4 | $474 |
| 6 | ROYAL MEDICAL PRIVATE LIMITED | $5.6K | 9 | 1 | $626 |
| 7 | RIZLIFE HEALTHCARE | $4.3K | 7 | 2 | $617 |
Aprazer Healthcare Private Limited ranks #5 among 56 Indian Axitinib exporters. Average shipment value of $474 compared to the market average of $1.1K. The closest competitors by value are RMPL PHARMA LLP and MEDINEX HEALTHCARE.
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 50 | 23.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 41 | 19.6% |
| SAHAR AIR | 33 | 15.8% |
| DELHI AIR | 31 | 14.8% |
| Bombay Air | 10 | 4.8% |
| HYDERABAD AIR | 9 | 4.3% |
| Delhi Air Cargo | 7 | 3.3% |
| Bombay Air Cargo | 6 | 2.9% |
Latest developments and market context
Detailed market intelligence for Axitinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 28+ countries, 77+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aprazer Healthcare Private Limited's Axitinib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aprazer Healthcare Private Limited
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Aprazer Healthcare Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Axitinib. For current shipment-level data, contact TransData Nexus.